封面
市場調查報告書
商品編碼
1672677

全球戒菸和尼古丁成癮治療產品市場按給藥途徑、產品、通路和地區分類

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, By Product, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 358 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球戒菸和尼古丁成癮治療產品市場規模估計為 194.1 億美元,預計到 2032 年將達到 593.6 億美元,2025 年至 2032 年的複合年成長率為 17.3%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 194.1億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 17.30% 2032 年價值預測 593.6億美元
市場佔有率。
戒菸及尼古丁戒菸產品市場-IMG1

由於世界吸菸人口的增加和對吸菸健康危害的認知不斷提高,全球戒菸和尼古丁成癮治療產品市場正在經歷顯著成長。吸菸已成為全球公共衛生問題,世界衛生組織(WHO)建議採取一系列措施幫助人們戒菸。尼古丁替代療法和其他戒菸輔助手段已被證明能有效幫助吸菸者戒除菸癮。各國政府和非政府組織所進行的多項宣傳宣傳活動增加了對尼古丁口香糖、貼片、含片和處方藥的需求,以幫助人們戒菸。產品配方和新技術的進步正在擴大想要戒菸的吸菸者的選擇。然而,某些戒菸產品的高成本以及菸癮的持續存在給該行業帶來了挑戰。

市場動態:

全球戒菸和尼古丁成癮治療產品市場的成長得益於吸菸相關疾病的日益流行、消費者健康意識的不斷增強以及政府當局為遏制菸草使用而採取的各種舉措。然而,某些戒菸療法的高成本以及菸草業強烈反對產品監管的遊說正在抑制市場的成長。此外,數位化解決方案在戒菸治療中的廣泛應用也帶來了新的機會。已經開發了各種行動應用程式和線上程式來提高尼古丁替代療法和消費者行為支援的有效性。尼古丁替代遞送形式的創新也是日益受到關注的一大趨勢。

本研究的主要特點

  • 本報告對全球戒菸和尼古丁成癮治療產品市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模和復合年成長率。
  • 它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
  • 它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
  • 報告深入分析了全球戒菸和尼古丁成癮治療產品市場的主要企業格局,包括其產品系列、主要亮點、業務表現和策略。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球戒菸和尼古丁成癮治療產品市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球戒菸和尼古丁成癮治療產品市場的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管情景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

4. 全球戒菸與尼古丁成癮治療產品市場:COVID-19 疫情的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 全球戒菸和尼古丁成癮治療產品市場依給藥途徑分類(2020-2032 年)

  • 口服
  • 經皮
  • 鼻腔
  • 舌下

6. 全球戒菸和尼古丁成癮治療產品市場(按產品分類)(2020-2032 年)

  • 尼古丁替代療法
  • 尼古丁噴霧
  • 尼古丁吸入器
  • 尼古丁口香糖
  • 尼古丁經皮吸收貼片
  • 尼古丁舌下片
  • 尼古丁含片
  • 藥物治療
  • Varenicline
  • Zyban
  • 尼可萊特·巴卡爾
  • 電子煙/電子液體

7. 全球戒菸和尼古丁成癮治療產品市場按分銷管道分類(2020-2032 年)

  • 院內藥房
  • 網路藥局
  • 零售藥局

8. 全球戒菸和尼古丁成癮治療產品市場(按地區) (2020-2032)

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 公司簡介
    • GlaxoSmithKline plc(GSK)
    • Pfizer Inc.
    • Johnson &Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc(BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

第 10 章分析師建議

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI134

Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 19.41 Bn in 2025 and is expected to reach USD 59.36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 19.41 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 17.30% 2032 Value Projection: USD 59.36 Bn
Figure. Smoking Cessation And Nicotine De-addiction Products Market Share (%), By Region 2025
Smoking Cessation and Nicotine De-addiction Products Market - IMG1

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

  • This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

  • By Route of Administration
    • Oral
    • Transdermal
    • Nasal
    • Sublingual
    • Oral
  • By Product
    • Nicotine Replacement Therapy
    • Nicotine Spray
    • Nicotine Inhalers
    • Nicotine Gum
    • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
    • Nicotine Lozenges
    • Drug Therapy
    • Varenicline
    • Zyban
    • Nicorette Buccal
    • E-cigarettes/E-liquid
  • By Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • GlaxoSmithKline plc (GSK)
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Product
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Transdermal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sublingual
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Nicotine Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Inhalers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Gum
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Transdermal Patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Sublingual Tablets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicotine Lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Varenicline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Zyban
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nicorette Buccal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • E-cigarettes/E-liquid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc (GSK)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact